Perceptive Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-100,000
Closed -$2.79M 170
2015
Q3
$2.79M Buy
+100,000
New +$3.61M 0.22% 69
2015
Q2
Sell
-100,000
Closed -$3.04M 186
2015
Q1
$3.04M Hold
100,000
0.24% 73
2014
Q4
$1.98M Buy
+100,000
New +$2.24M 0.17% 89
2014
Q2
Sell
-45,000
Closed -$579K 136
2014
Q1
$579K Sell
45,000
-120,000
-73% -$1.72M 0.06% 93
2013
Q4
$2.25M Buy
165,000
+96,700
+142% +$1.15M 0.27% 48
2013
Q3
$757K Buy
+68,300
New +$680K 0.06% 77

Other funds holding RGEN

Perceptive Advisors's RGEN Position: Q1 2026 in Review

Perceptive Advisors reduced its Repligen (RGEN) stake by 11% in Q1 2026, selling an estimated $4.89M and leaving 280,541 shares worth $33.1M. The position accounts for 0.65% of the portfolio, ranked #36.

Perceptive Advisors first reported a position in RGEN in Q3 2017 and has held it in 8 quarters since. The position peaked at $51.7M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Perceptive Advisors held 280,541 shares of Repligen worth $33.1M as of Q1 2026.
  • Perceptive Advisors sold 35,000 Repligen shares in Q1 2026, an estimated $4.89M.
  • Repligen made up 0.65% of Perceptive Advisors's portfolio in Q1 2026, its #36 holding.
  • Perceptive Advisors first reported a position in Repligen in Q3 2017 and has held it in 8 quarters since.
  • Perceptive Advisors's Repligen position peaked at $51.7M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.